These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 1908604

  • 1. Oral almitrine in treatment of acute respiratory failure and cor pulmonale in patients with an exacerbation of chronic obstructive airways disease.
    Bardsley PA, Tweney J, Morgan N, Howard P.
    Thorax; 1991 Jul; 46(7):493-8. PubMed ID: 1908604
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Almitrine bismesylate and oxygen therapy in hypoxic cor pulmonale.
    Evans TW, Tweney J, Waterhouse JC, Nichol J, Suggett AJ, Howard P.
    Thorax; 1990 Jan; 45(1):16-21. PubMed ID: 2108510
    [Abstract] [Full Text] [Related]

  • 4. Sequential treatment with low dose almitrine bismesylate in hypoxaemic chronic obstructive airways disease.
    Bardsley PA, Howard P, Tang O, Empey D, Harrison B, Peake MD, O'Reilly J, Riordan JF, Wilkinson J, Arnaud F.
    Eur Respir J; 1992 Oct; 5(9):1054-61. PubMed ID: 1426214
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Almitrine bismesylate in chronic obstructive lung disease and persistent hypoxemia. Controlled double-blind study with oral administration].
    Wuttke R, von Wichert P.
    Respiration; 1985 Oct; 48(4):285-95. PubMed ID: 3936140
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. One year treatment with almitrine improves hypoxaemia but does not increase pulmonary artery pressure in COPD patients.
    Weitzenblum E, Schrijen F, Apprill M, Prefaut C, Yernault JC.
    Eur Respir J; 1991 Nov; 4(10):1215-22. PubMed ID: 1804669
    [Abstract] [Full Text] [Related]

  • 13. Dose-response and pharmacokinetic study with almitrine bismesylate after single oral administrations in COPD patients.
    Bury T, Jeannot JP, Ansquer JC, Radermecker M.
    Eur Respir J; 1989 Jan; 2(1):49-55. PubMed ID: 2495983
    [Abstract] [Full Text] [Related]

  • 14. Comparison of almitrine bismesylate and medroxyprogesterone acetate on oxygenation during wakefulness and sleep in patients with chronic obstructive lung disease.
    Daskalopoulou E, Patakas D, Tsara V, Zoglopitis F, Maniki E.
    Thorax; 1990 Sep; 45(9):666-9. PubMed ID: 2145654
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term effects of almitrine bismesylate in COPD patients with chronic hypoxaemia.
    Sans-Torres J, Domingo C, Morón A, Rué M, Marín A.
    Respir Med; 2003 Jun; 97(6):599-605. PubMed ID: 12814142
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Double-blind placebo controlled clinical trial of almitrine bismesylate in patients with chronic respiratory insufficiency.
    Bakran I, Vrhovac B, Stangl B, Tabori D, Ivicevic A, Todic V, Kandare F.
    Eur J Clin Pharmacol; 1990 Jun; 38(3):249-53. PubMed ID: 2187700
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.